ArticleEuropean journal of haematology2026

Development of Chimeric Antigen Receptor-Modified NK Cells for the Immunotherapy of Adult T-Cell Leukemia/Lymphoma.

Yuichiro Uchida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.